Meeting of the National Vaccine Advisory Committee, 51571-51572 [2015-20943]

Download as PDF 51571 Federal Register / Vol. 80, No. 164 / Tuesday, August 25, 2015 / Notices enable HRSA to provide aggregate program data required by Congress under the Government Performance and Results Act (GPRA) of 1993. These measures cover the principal topic areas of interest to the Federal Office of Rural Health Policy (FORHP), including: (a) Access to care; (b) population demographics; (c) staffing; (d) consortium/network; (e) sustainability; and (f) benefits counseling process and outcomes. Several measures will be used for the Benefits Counseling Program. All measures will speak to FORHP’s progress toward meeting the goals set. A 60-day Federal Register Notice was published in the Federal Register on June 1, 2015 (80 FR 31051). There were no comments. Likely Respondents: The respondents would be recipients of the Rural Outreach Benefits Counseling grant funding. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours Rural Outreach Benefits Counseling Grant Program Measures ................................................................................... 10 1 10 2 20 Total .............................................................................. 10 1 10 2 20 Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2015–21009 Filed 8–24–15; 8:45 am] BILLING CODE 4165–15–P NVAC Web site at https://www.hhs.gov/ nvpo/nvac/meetings/ upcomingmeetings/ as soon as they become available. U.S. Department of Health and Human Services, Hubert H. Humphrey Building, the Great Hall, 200 Independence Avenue SW., Washington, DC 20201. The meeting can also be accessed through a live webcast the day of the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/. ADDRESSES: DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting September 9–10, 2015. The meeting is open to the public. However, preregistration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at https://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/. Participants may also register by emailing nvpo@hhs.gov or by calling 202–690–5566 and providing their name, organization, and email address. DATES: The meeting will be held on September 9–10, 2015. The meeting times and agenda will be posted on the asabaliauskas on DSK5VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:10 Aug 24, 2015 Jkt 235001 FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690–5566; email: nvpo@ hhs.gov. Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 During the September NVAC meeting, the Committee will hear updates on a number of Departmental and stakeholder activities that are working to strengthen our national immunization system. The Committee will hear an update on progress towards the Healthy People 2020 immunization goals, followed by presentations specifically examining progress towards the Healthy People 2020 goal to achieve 90% influenza vaccination coverage among healthcare personnel. In particular, the Committee will look at challenges and opportunities for helping improve influenza vaccination among healthcare personnel in long-term care settings. The Committee also will hear about efforts to support global immunization including an introduction to a number of global immunization strategies currently under development such as an update to the CDC’s Global Immunization Strategic Framework, the newly established USAID Immunization Blueprint for Action, and the Pan American Health Organization’s proposed Regional Plan of Action on Immunization. In addition, the NVAC will hear a brief overview describing the success of efforts to develop the first Ebola vaccine. The Committee will be presented with information on how data on state exemption laws is collected and used to inform studies on vaccination coverage and vaccine acceptance in specific populations. NVAC will also host a session continuing their discussions on vaccine confidence that will include E:\FR\FM\25AUN1.SGM 25AUN1 51572 Federal Register / Vol. 80, No. 164 / Tuesday, August 25, 2015 / Notices studies looking at how attitudes and beliefs about immunizations change over time. Finally, the Committee will be provided with information on local and federal efforts to help increase vaccine confidence in communities. More information on the meeting agenda will be posted prior to the meeting on the NVAC Web site: https:// www.hhs.gov/nvpo/nvac/meetings/ upcomingmeetings/. Public attendance at the meeting is limited to the available space. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the webcast can be found at https://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/. Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit their written comments. Written comments should not exceed three pages in length. Individuals submitting written comments should email their comments to the National Vaccine Program Office (nvpo@hhs.gov) at least five business days prior to the meeting. Dated: August 17, 2015. Jennifer L. Gordon, Alternate Designated Federal Official, National Vaccine Advisory Committee, National Vaccine Program Office. [FR Doc. 2015–20943 Filed 8–24–15; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health asabaliauskas on DSK5VPTVN1PROD with NOTICES National Institute of Diabetes and Digestive and Kidney Diseases Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and VerDate Sep<11>2014 17:10 Aug 24, 2015 Jkt 235001 the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Small Grants for New Investigators. Date: September 8, 2015. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Contact Person: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 750, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, 301–594–8886, sanoviche@mail.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; PAR–14–301: NIDDK Central Repositories Non-renewable Sample Access (X01)-Biomarkers for T1D. Date: September 21, 2015. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Najma Begum, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 749, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8894, begumn@niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; PAR–15–067: NIDDK Multi-Center Clinical Study (U01). Date: October 6, 2015. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Dianne Camp, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, 301–594–7682, campd@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Nutrition Obesity Research Centers. Date: November 18, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave. NW., Washington, DC 20037. Contact Person: Thomas A. Tatham, Ph.D., Scientific Review Officer, Review Branch, PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 DEA, NIDDK, National Institutes of Health, Room 760, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–3993, tathamt@mail.nih.gov. National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; PAR–13–074: Small R03 Grants for New Investigators. Date: November 19, 2015. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Jian Yang, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 755, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7799, yangj@ extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: August 20, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–21007 Filed 8–24–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Surveys To Support an Evaluation of the National Human Genome Research Institute (NHGRI) Summer Workshop in Genomics (Short Course) Under the provisions of Section 3507(a)(l)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on March 17, 2015, Vol. 80, Page 13845 and allowed 60days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Human Genome Research Institute (NHGRI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, SUMMARY: E:\FR\FM\25AUN1.SGM 25AUN1

Agencies

[Federal Register Volume 80, Number 164 (Tuesday, August 25, 2015)]
[Notices]
[Pages 51571-51572]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20943]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
September 9-10, 2015. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/. Participants may also register by emailing 
nvpo@hhs.gov or by calling 202-690-5566 and providing their name, 
organization, and email address.

DATES: The meeting will be held on September 9-10, 2015. The meeting 
times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/ as soon as they become 
available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, the Great Hall, 200 Independence Avenue SW., 
Washington, DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    During the September NVAC meeting, the Committee will hear updates 
on a number of Departmental and stakeholder activities that are working 
to strengthen our national immunization system. The Committee will hear 
an update on progress towards the Healthy People 2020 immunization 
goals, followed by presentations specifically examining progress 
towards the Healthy People 2020 goal to achieve 90% influenza 
vaccination coverage among healthcare personnel. In particular, the 
Committee will look at challenges and opportunities for helping improve 
influenza vaccination among healthcare personnel in long-term care 
settings.
    The Committee also will hear about efforts to support global 
immunization including an introduction to a number of global 
immunization strategies currently under development such as an update 
to the CDC's Global Immunization Strategic Framework, the newly 
established USAID Immunization Blueprint for Action, and the Pan 
American Health Organization's proposed Regional Plan of Action on 
Immunization. In addition, the NVAC will hear a brief overview 
describing the success of efforts to develop the first Ebola vaccine.
    The Committee will be presented with information on how data on 
state exemption laws is collected and used to inform studies on 
vaccination coverage and vaccine acceptance in specific populations. 
NVAC will also host a session continuing their discussions on vaccine 
confidence that will include

[[Page 51572]]

studies looking at how attitudes and beliefs about immunizations change 
over time. Finally, the Committee will be provided with information on 
local and federal efforts to help increase vaccine confidence in 
communities. More information on the meeting agenda will be posted 
prior to the meeting on the NVAC Web site: https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office (nvpo@hhs.gov) at least five 
business days prior to the meeting.

    Dated: August 17, 2015.
Jennifer L. Gordon,
Alternate Designated Federal Official, National Vaccine Advisory 
Committee, National Vaccine Program Office.
[FR Doc. 2015-20943 Filed 8-24-15; 8:45 am]
 BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.